Our retrospective study has revealed that ESCC patients exhibiting elevated levels of FLG-AS1 and HOXD10, in conjunction with diminished expression of miR-23a-3p, demonstrate a significantly improved 5-year survival rate post-surgery. Here, HOXD10 is linked to esophageal squamous cell carcinoma.